{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:31:05Z","timestamp":1786336265390,"version":"build-2736575974"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Breast cancer is a heterogeneous disease, and accurate preoperative identification of molecular subtypes is essential for guiding individualized treatment and prognostic evaluation. However, histopathological assessment, the current gold standard, is invasive and limited by intratumoral heterogeneity, underscoring the need for reliable noninvasive alternatives. Radiomics based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has shown promise for molecular subtype prediction; nevertheless, the optimal radiomic features for automated molecular classification remain to be fully elucidated. To address this gap, this study aims to identify optimal DCE-MRI radiomic features and to develop radiomics-based machine learning models for predicting breast cancer molecular subtypes. Specifically, regions of interest were manually delineated on DCE-MRI images for feature extraction, followed by feature selection to identify the most informative radiomic parameters. Four machine learning classifiers (RF, SVM, LR, GBDT) were then constructed to predict five molecular subtypes of breast cancer. The experimental results demonstrate that the optimized DCE-MRI\u2013based radiomics model effectively predicts breast cancer molecular subtypes. In particular, the gradient boosting decision tree (GBDT) model combined with rigorous feature selection shows high predictive performance, highlighting its strong potential for noninvasive, accurate, and clinically applicable molecular classification of breast cancer.<\/jats:p>","DOI":"10.3389\/fonc.2026.1794638","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:23:06Z","timestamp":1786335786000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploiting machine-learning models with DCE-MRI radiomics for breast cancer molecular subtyping"],"prefix":"10.3389","volume":"16","author":[{"given":"Yang","family":"Lou","sequence":"first","affiliation":[{"name":"Department of Radiology, Affiliated Hospital of Hebei University","place":["Baoding, Hebei, China"]},{"name":"Hebei Key Laboratory of Precise Imaging of Inflammation-Related Tumors, Affiliated Hospital of Hebei University","place":["Baoding, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Affiliated Hospital of Hebei University","place":["Baoding, Hebei, China"]},{"name":"Hebei Key Laboratory of Precise Imaging of Inflammation-Related Tumors, Affiliated Hospital of Hebei University","place":["Baoding, Hebei, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2018.03.002","article-title":"Global analysis of advanced\/metastatic breast cancer: Decade report, (2005\u20132015)","volume":"39","author":"Cardoso","year":"2018","journal-title":"Breast"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the st gallen international expert consensus on the primary therapy of early breast cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1107850","article-title":"Cross-attention multi-branch cnn using dce-mri to classify breast cancer molecular subtypes","volume":"13","author":"Sun","year":"2023","journal-title":"Front Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1259\/bjro.20210034","article-title":"Contrast-enhanced mammography: what the radiologist needs to know","volume":"3","author":"Neeter","year":"2021","journal-title":"BJR Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejmp.2020.10.025","article-title":"Recent advances in x-ray imaging of breast tissue: From two- to three-dimensional imaging","volume":"79","author":"Heck","year":"2020","journal-title":"Phys Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2021.12.010","article-title":"Quantifying lesion enhancement on contrast-enhanced mammography: a review of published data","volume":"77","author":"Savaridas","year":"2022","journal-title":"Clin Radiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202206_289514","article-title":"Mr imaging properties of breast cancer molecular subtypes","volume":"26","author":"Seyfettin","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24879","article-title":"Computational approach to radiogenomics of breast cancer: Luminal a and luminal b molecular subtypes are associated with imaging features on routine breast mri extracted using computer vision algorithms","volume":"42","author":"Grimm","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2015.07.002","article-title":"Breast cancer in very young women (\u00a130 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes","volume":"84","author":"An","year":"2015","journal-title":"Eur J Radiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-020-01001-8","article-title":"Correlation between imaging features and molecular subtypes of breast cancer in young women (\u226430 years old)","volume":"38","author":"Huang","year":"2020","journal-title":"Jpn J Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.12182","article-title":"Mr imaging features of triple-negative breast cancers","volume":"19","author":"Sung","year":"2013","journal-title":"Breast J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202011_23793","article-title":"Correlation study between the magnetic resonance imaging features of breast cancer and expression of immune molecular subtypes","volume":"24","author":"Long","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mri.2024.07.001","article-title":"Radiomics-based analysis of dynamic contrast-enhanced magnetic resonance image: A prediction nomogram for lymphovascular invasion in breast cancer","volume":"112","author":"Yang","year":"2024","journal-title":"Magn Reson Imaging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29060","article-title":"Assessment of lymphovascular invasion in breast cancer using a combined MRI morphological features, radiomics, and deep learning approach based on dynamic contrast-enhanced MRI","volume":"59","author":"Yang","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2023.11.017","article-title":"Delta-radiomics based on dynamic contrast-enhanced MRI for predicting lymphovascular invasion in invasive breast cancer","volume":"31","author":"Zheng","year":"2024","journal-title":"Acad Radiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S497770","article-title":"The clinical study of intratumoral and peritumoral radiomics based on DCE-MRI for HER-2 positive and low expression prediction in breast cancer","volume":"16","author":"Shang","year":"2024","journal-title":"Breast Cancer: Targets Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.24.31717","article-title":"Multiparametric MRI radiomics with machine learning for differentiating HER2-zero, -low, and -positive breast cancer: Model development, testing, and interpretability analysis","volume":"224","author":"Chen","year":"2025","journal-title":"AJR Am J Roentgenology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29670","article-title":"Development and validation of a deep learning system to differentiate HER2-zero, HER2-low, and HER2-positive breast cancer based on dynamic contrast-enhanced MRI","volume":"61","author":"Dai","year":"2025","journal-title":"J Magn Reson Imaging"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1593075","article-title":"Predicting histological grade in invasive ductal carcinoma of the breast: A radiomics-based machine learning model using DCE-MRI","volume":"15","author":"Wang","year":"2025","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1765392","article-title":"Multiparametric MRI radiomics for noninvasive prediction of HER2 status in immunohistochemical 2+ breast cancer","volume":"15","author":"Li","year":"2025","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of american pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J R Stat Society: Ser B (Methodological)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: The bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.2020200029","article-title":"Checklist for artificial intelligence in medical imaging (CLAIM): A guide for authors and reviewers","volume":"2","author":"Mongan","year":"2020","journal-title":"Radiology: Artif Intell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/BF00994018","article-title":"Support-vector networks","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach Learn"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1958.tb00292.x","article-title":"The regression analysis of binary sequences","volume":"20","author":"Cox","year":"1958","journal-title":"J R Stat Society: Ser B (Methodological)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: A gradient boosting machine","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann Stat"},{"key":"B31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12880-017-0239-z","article-title":"Mri texture analysis in differentiating luminal a and luminal b breast cancer molecular subtypes - a feasibility study","volume":"17","author":"Holli-Helenius","year":"2017","journal-title":"BMC Med Imaging"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-3845-6","article-title":"Magnetic resonance imaging texture analysis classification of primary breast cancer","volume":"26","author":"Waugh","year":"2016","journal-title":"Eur Radio"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.25661","article-title":"Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation","volume":"46","author":"Wu","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2024.100585","article-title":"The association of magnetic resonance imaging features with five molecular subtypes of breast cancer","volume":"13","author":"Nguyen","year":"2024","journal-title":"Eur J Radiol Open"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2022.04.004","article-title":"Dce-mri radiomics analysis in differentiating luminal a and luminal b breast cancer molecular subtypes","volume":"30","author":"Lafc\u0131","year":"2023","journal-title":"Acad Radiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234800","article-title":"Preliminary study on discriminating her2 2+ amplification status of breast cancers based on texture features semi-automatically derived from pre-, post-contrast, and subtraction images of dce-mri","volume":"15","author":"Song","year":"2020","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2174\/1573405618666220225090944","article-title":"Dce-mri performance in triple negative breast cancers: Comparison with non-triple negative breast cancers","volume":"18","author":"Chen","year":"2022","journal-title":"Curr Med Imaging"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S210583","article-title":"Added value of histogram analysis of apparent diffusion coefficient maps for differentiating triple-negative breast cancer from other subtypes of breast cancer on standard mri","volume":"11","author":"Liu","year":"2019","journal-title":"Cancer Manage Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58121716","article-title":"Multiparametric mri features of breast cancer molecular subtypes","volume":"58","author":"Szep","year":"2022","journal-title":"Med (Kaunas)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1700248","article-title":"Kinetic and radiomic features on DCE-MRI as a predictor for axillary lymph node metastasis burden in T1 and T2 stage breast cancer","volume":"15","author":"Liu","year":"2025","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1794638\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:23:07Z","timestamp":1786335787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1794638\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":40,"alternative-id":["10.3389\/fonc.2026.1794638"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1794638","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1794638"}}